Risk of malignancy in patients with asthma-COPD overlap compared to patients with COPD without asthma
B. Bonnesen (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), A. Jordan (Hellerup, Denmark), J. Wirenfeldt Pedersen (Herlev, Denmark), C. Marisa Bergsøe (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), L. Lindhardt Toennesen (Hellerup, Denmark), S. Graff Jensen (Hellerup, Denmark), M. Naqibullah (Hellerup, Denmark), Z. Saghir (Hellerup, Denmark), J. Jensen (Hellerup, Denmark)
Source: International Congress 2022 – Clinical problems and management of airway diseases
Session: Clinical problems and management of airway diseases
Session type: Thematic Poster
Number: 1647
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Bonnesen (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), A. Jordan (Hellerup, Denmark), J. Wirenfeldt Pedersen (Herlev, Denmark), C. Marisa Bergsøe (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), L. Lindhardt Toennesen (Hellerup, Denmark), S. Graff Jensen (Hellerup, Denmark), M. Naqibullah (Hellerup, Denmark), Z. Saghir (Hellerup, Denmark), J. Jensen (Hellerup, Denmark). Risk of malignancy in patients with asthma-COPD overlap compared to patients with COPD without asthma. 1647
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|